Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panpan Shen

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Journal of Biological Macromolecules|March 28, 2026
Structure-guided protein engineering and immobilization of an amidohydrolase for efficient ochratoxin a detoxificationYumei Hu, Yuhang Xu, Biyu He, et al.
Nature|March 5, 2025
Chanoclavine synthase operates by an NADPH-independent superoxide mechanismChun-Chi Chen, Zhi-Pu Yu, Ziwei Liu, et al.
Nature|September 6, 2023
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cellsLinjie Yuan, Xianqiang Ma, Yunyun Yang, et al.
Cancer Cell|August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancersJuanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Biological Macromolecules|March 28, 2026
Structure-guided protein engineering and immobilization of an amidohydrolase for efficient ochratoxin a detoxificationYumei Hu, Yuhang Xu, Biyu He, et al.
Nature|March 5, 2025
Chanoclavine synthase operates by an NADPH-independent superoxide mechanismChun-Chi Chen, Zhi-Pu Yu, Ziwei Liu, et al.
Nature|September 6, 2023
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cellsLinjie Yuan, Xianqiang Ma, Yunyun Yang, et al.
Cancer Cell|August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancersJuanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.
Pageof 3